Protein production from the structural genomics perspective: Achievements and future needs

Current Opinion in Structural Biology

Volumn 23, Issue 3, 2013, Pages 335-344

  Almo, Steven C ^a   Garforth, Scott J ^a   Hillerich, Brandan S ^a   Love, James D ^a   Seidel, Ronald D ^a   Burley, Stephen K ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN;

AUTOMATION; EUKARYOTE; EXPRESSION VECTOR; FERMENTATION; GENE AMPLIFICATION; GENE EXPRESSION SYSTEM; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; REVIEW; STRUCTURAL GENOMICS;

ANIMALS; COMPUTATIONAL BIOLOGY; EUKARYOTIC CELLS; GENE EXPRESSION; GENOMICS; HIGH-THROUGHPUT SCREENING ASSAYS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS;

EUKARYOTA; HEXAPODA; MAMMALIA;

EID: 84879185251     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2013.02.014     Document Type: Review

References (65)

1. Elsliger M.A., Deacon A.M., Godzik A., Lesley S.A., Wooley J., Wüthrich K., Wilson I.A. The JCSG high-throughput structural biology pipeline. Acta Crystallogr Sect F: Struct Biol Cryst Commun 2010, 66:1137-1142.
2. Kim Y., Babnigg G., Jedrzejczak R., Eschenfeldt W.H., Li H., Maltseva N., Hatzos-Skintges C., Gu M., Makowska-Grzyska M., Wu R., et al. High-throughput protein purification and quality assessment for crystallization. Methods 2011, 55:12-28.
3. Love J., Mancia F., Shapiro L., Punta M., Rost B., Girvin M., Wang D.-N., Zhou M., Hunt J.F., Szyperski T., et al. The New York Consortium on Membrane Protein Structure (NYCOMPS): a high-throughput platform for structural genomics of integral membrane proteins. J Struct Funct Genomics 2010, 11:191-199.
4. Sauder M.J., Rutter M.E., Bain K., Rooney I., Gheyi T., Atwell S., Thompson D.A., Emtage S., Burley S.K. High throughput protein production and crystallization at NYSGXRC. Methods Mol Biol 2008, 426:561-575.
5. Xiao R., Anderson S., Aramini J., Belote R., Buchwald W.A., Ciccosanti C., Conover K., Everett J.K., Hamilton K., Huang Y.J., et al. The high-throughput protein sample production platform of the Northeast Structural Genomics Consortium. J Struct Biol 2010, 172:21-33.
6. Gräslund S., Nordlund P., Weigelt J., Hallberg B.M., Bray J., Gileadi O., Knapp S., Oppermann U., Arrowsmith C., Hui R., et al. Protein production and purification. Nat Methods 2008, 5:135-146.
7. Aslanidis C., de Jong PJ Ligation-independent cloning of PCR products (LIC-PCR). Nucleic Acids Res 1990, 18:6069-6074.
8. Klock H.E., Lesley S.A. The Polymerase Incomplete Primer Extension (PIPE) method applied to high-throughput cloning and site-directed mutagenesis. Methods Mol Biol 2009, 498:91-103.
9. Esposito D., Garvey L.A., Chakiath C.S. Gateway cloning for protein expression. Methods Mol Biol 2009, 498:31-54.
10. Bhikhabhai R., Sjöberg A., Hedkvist L., Galin M., Liljedahl P., Frigård T., Pettersson N., Nilsson M., Sigrell-Simon J.A., Markeland-Johansson C. Production of milligram quantities of affinity tagged-proteins using automated multistep chromatographic purification. J Chromatogr A 2005, 1080:83-92.
11. Prater B.D., Anumula K.R., Hutchins J.T. Automated sample preparation facilitated by PhyNexus MEA purification system for oligosaccharide mapping of glycoproteins. Anal Biochem 2007, 369:202-209.
12. Vincentelli R., Cimino A., Geerlof A., Kubo A., Satou Y., Cambillau C. High-throughput protein expression screening and purification in Escherichia coli. Methods 2011, 55:65-72.
13. Pacheco B., Crombet L., Loppnau P., Cossar D. A screening strategy for heterologous protein expression in Escherichia coli with the highest return of investment. Protein Expr Purif 2012, 81:33-41.
14. Bird L.E. High throughput construction and small scale expression screening of multi-tag vectors in Escherichia coli. Methods 2011, 55:29-37.
15. Gräslund S., Sagemark J., Berglund H., Dahlgren L.-G., Flores A., Hammarström M., Johansson I., Kotenyova T., Nilsson M., Nordlund P., et al. The use of systematic N- and C-terminal deletions to promote production and structural studies of recombinant proteins. Protein Expr Purif 2008, 58:210-221.
16. Page R., Moy K., Sims E.C., Velasquez J., McManus B., Grittini C., Clayton T.L., Stevens R.C. Scalable high-throughput micro-expression device for recombinant proteins. Biotechniques 2004, 37:364-370.
17. Lukk T., Sakai A., Kalyanaraman C., Brown S.D., Imker H.J., Song L., Fedorov A.A., Fedorov E.V., Toro R., Hillerich B., et al. Homology models guide discovery of diverse enzyme specificities among dipeptide epimerases in the enolase superfamily. Proc Natl Acad Sci U S A 2012, 109:4122-4127.
18. Gerlt J.A., Allen K.N., Almo S.C., Armstrong R.N., Babbitt P.C., Cronan J.E., Dunaway-Mariano D., Imker H.J., Jacobson M.P., Minor W., et al. The Enzyme Function Initiative. Biochemistry 2011, 50:9950-9962.
19. Smith G.E., Summers M.D., Fraser M.J. Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 1983, 3:2156-2165.
20. Hitchman R.B., Possee R.D., King L.A. High-throughput baculovirus expression in insect cells. Methods Mol Biol 2012, 824:609-627.
21. Hitchman R.B., Possee R.D., Crombie A.T., Chambers A., Ho K., Siaterli E., Lissina O., Sternard H., Novy R., Loomis K., et al. Genetic modification of a baculovirus vector for increased expression in insect cells. Cell Biol Toxicol 2010, 26:57-68.
22. Pijlman G.P., Roode E.C., Fan X., Roberts L.O., Belsham G.J., Vlak J.M., van Oers MM Stabilized baculovirus vector expressing a heterologous gene and GP64 from a single bicistronic transcript. J Biotechnol 2006, 123:13-21.
23. Tiwari P., Saini S., Upmanyu S., Benjamin B., Tandon R., Saini K.S., Sahdev S. Enhanced expression of recombinant proteins utilizing a modified baculovirus expression vector. Mol Biotechnol 2010, 46:80-89.
24. Manohar S.L., Kanamasa S., Nishina T., Kato T., Park EY Enhanced gene expression in insect cells and silkworm larva by modified polyhedrin promoter using repeated Burst sequence and very late transcriptional factor-1. Biotechnol Bioeng 2010, 107:909-916.
25. Hashimoto Y., Zhang S., Zhang S., Chen Y.-R., Blissard G.W. Correction: BTI-Tnao38, a new cell line derived from Trichoplusia ni, is permissive for AcMNPV infection and produces high levels of recombinant proteins. BMC Biotechnol 2012, 12:12.
26. Loomis K.H., Yaeger K.W., Batenjany M.M., Mehler M.M., Grabski A.C., Wong S.C., Novy R.E. InsectDirect System: rapid, high-level protein expression and purification from insect cells. J Struct Funct Genomics 2005, 6:189-194.
27. ® bioreactor 50 tubes. BMC Proc 2011, 5(Suppl 8):37.
28. Barbin K., Stieglmaier J., Saul D., Stieglmaier K., Stockmeyer B., Pfeiffer M., Lang P., Fey G.H. Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies. J Immunother 2006, 29:122-133.
29. Chang V.T., Crispin M., Aricescu A.R., Harvey D.J., Nettleship J.E., Fennelly J.A., Yu C., Boles K.S., Evans E.J., Stuart D.I., et al. Glycoprotein structural genomics: solving the glycosylation problem. Structure 2007, 15:267-273.
30. Freedman R.B., Jenkins N., James D.C., Goldman M.H., Hoare M., Oliver R.W.A., Green B.N. Posttranslational processing of recombinant human interferon-γ in animal expression systems. Protein Sci 1996, 5:331-340.
31. Hossler P., Khattak S.F., Li Z.J. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 2009, 19:936-949.
32. Bork K., Horstkorte R., Weidemann W Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway. J Pharm Sci 2009, 98:3499-3508.
33. Jenkins N., Parekh R.B., James D.C. Getting the glycosylation right: implications for the biotechnology industry. Nat Biotechnol 1996, 14:975-981.
34. Loos A., Steinkellner H. IgG-Fc glycoengineering in non-mammalian expression hosts. Arch Biochem Biophys 2012, 526:167-173.
35. Valderrama-Rincon J.D., Fisher A.C., Merritt J.H., Fan Y.-Y., Reading C.A., Chhiba K., Heiss C., Azadi P., Aebi M., DeLisa M.P. An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat Chem Biol 2012, 8:434-436.
36. Zhang N., Liu L., Dumitru C.D., Cummings N.R.H., Cukan M., Jiang Y., Li Y., Li F., Mitchell T., Mallem M.R., et al. Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study. MAbs 2011, 3:289-298.
37. Palmberger D., Wilson I.B.H., Berger I., Grabherr R., Rendic D. SweetBac: a new approach for the production of mammalianised glycoproteins in insect cells. PLoS ONE 2012, 7:e34226.
38. Strasser R., Stadlmann J., Schähs M., Stiegler G., Quendler H., Mach L., Glössl J., Weterings K., Pabst M., Steinkellner H. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 2008, 6:392-402.
39. Castilho A., Strasser R., Stadlmann J., Grass J., Jez J., Gattinger P., Kunert R., Quendler H., Pabst M., Leonard R., et al. In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 2010, 285:15923-15930.
40. Baldi L., Hacker D.L., Meerschman C., Wurm F.M. Large-scale transfection of mammalian cells. Methods Mol Biol 2012, 801:13-26.
41. Durocher Y., Perret S., Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 2002, 30:E9.
42. Raymond C., Tom R., Perret S., Moussouami P., L'abbé D., St-Laurent G., Durocher Y. A simplified polyethylenimine-mediated transfection process for large-scale and high-throughput applications. Methods 2011, 55:44-51.
43. Kiseljak D., Rajendra Y., Manoli S.S., Baldi L., Hacker D.L., Wurm F.M. The use of filler DNA for improved transfection and reduced DNA needs in transient gene expression with CHO and HEK cells. BMC Proc 2011, 5(Suppl 8):33.
44. Oberbek A., Matasci M., Hacker D.L., Wurm F.M. Generation of stable, high-producing CHO cell lines by lentiviral vector-mediated gene transfer in serum-free suspension culture. Biotechnol Bioeng 2011, 108:600-610.
45. Bandaranayake A.D., Correnti C., Ryu B.Y., Brault M., Strong R.K., Rawlings D.J. Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors. Nucleic Acids Res 2011, 39:e143.
46. Gaillet B., Gilbert R., Broussau S., Pilotte A., Malenfant F., Mullick A., Garnier A., Massie B. High-level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch. Biotechnol Bioeng 2010, 106:203-215.
47. De Jesus M.J., Girard P., Bourgeois M., Baumgartner G., Jacko B., Amstutz H., Wurm F.M. TubeSpin satellites: a fast track approach for process development with animal cells using shaking technology. Biochem Eng J 2004, 17:217-223.
48. Weber W., Fussenegger M. Inducible product gene expression technology tailored to bioprocess engineering. Curr Opin Biotechnol 2007, 18:399-410.
49. Qiao J., Oumard A., Wegloehner W., Bode J. Novel tag-and-exchange (RMCE) strategies generate master cell clones with predictable and stable transgene expression properties. J Mol Biol 2009, 390:579-594.
50. Zhou H., Liu Z.-G., Sun Z.-W., Huang Y., Yu W.-Y. Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system. J Biotechnol 2010, 147:122-129.
51. Kingston R.E., Kaufman R.J., Bebbington C.R., Rolfe M.R. Amplification using CHO cell expression vectors. Curr Protocols Mol Biol 2002, 16.23.1-16.23.13.
52. Barnes L.M., Bentley C.M., Dickson AJ Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 2000, 32:109-123.
53. Kim W.H., Kim M.S., Kim Y.G., Lee G.M. Development of apoptosis-resistant CHO cell line expressing PyLT for the enhancement of transient antibody production. Process Biochem 2012, 47:2557-2561.
54. Gonzalez R., Jennings L.L., Knuth M., Orth A.P., Klock H.E., Ou W., Feuerhelm J., Hull M.V., Koesema E., Wang Y., et al. Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency. Proc Natl Acad Sci U S A 2010, 107:3552-3557.
55. Shapiro L., Weis W.I. Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 2009, 1:a003053.
56. Ye F., Kim C., Ginsberg M.H. Molecular mechanism of inside-out integrin regulation. J Thromb Haemost 2011, 9(Suppl 1):20-25.
57. Fernandez-Martinez J., Rout M.P. A jumbo problem: mapping the structure and functions of the nuclear pore complex. Curr Opin Cell Biol 2012, 24:92-99.
58. Chattopadhyay K., Lazar-Molnar E., Yan Q., Rubinstein R., Zhan C., Vigdorovich V., Ramagopal U.A., Bonanno J., Nathenson S.G., Almo S.C. Sequence, structure, function, immunity: structural genomics of costimulation. Immunol Rev 2009, 229:356-386.
59. Trowitzsch S., Bieniossek C., Nie Y., Garzoni F., Berger I. New baculovirus expression tools for recombinant protein complex production. J Struct Biol 2010, 172:45-54.
60. Bieniossek C., Papai G., Schaffitzel C., Garzoni F., Chaillet M., Scheer E., Papadopoulos P., Tora L., Schultz P., Berger I. The architecture of human general transcription factor TFIID core complex. Nature 2013, 493:699-702.
61. Fraser J.S., Gross J.D., Krogan N.J. From systems to structure: bridging networks and mechanism. Mol Cell 2013, 49:222-231.
62. Neveu G., Cassonnet P., Vidalain P.-O., Rolloy C., Mendoza J., Jones L., Tangy F., Muller M., Demeret C., Tafforeau L., et al. Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase. Methods 2012, 58:349-359.
63. Jäger S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., et al. Global landscape of HIV-human protein complexes. Nature 2012, 481:365-370.
64. Li X., Gianoulis T.A., Yip K.Y., Gerstein M., Snyder M. Extensive in vivo metabolite-protein interactions revealed by large-scale systematic analyses. Cell 2010, 143:639-650.
65. Zhang M., Gaschen B., Blay W., Foley B., Haigwood N., Kuiken C., Korber B. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004, 14:1229-1246.